glucosamine has been researched along with 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bounelis, P; Chatham, JC; Marchase, RB; Pang, Y | 1 |
1 other study(ies) available for glucosamine and 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole
| Article | Year |
|---|---|
Hexosamine pathway is responsible for inhibition by diabetes of phenylephrine-induced inotropy.
Topics: Animals; Calcium; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Endoplasmic Reticulum; Glucosamine; Heart Rate; Hexosamines; Imidazoles; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Male; Myocardial Contraction; Phenylephrine; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum; Type C Phospholipases; Ventricular Function, Left | 2004 |